A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Advancements in image-based technologies and body composition research over the past decade has led to increased understanding of the importance of muscle abnormalities, such as low muscle mass (sarcopenia), and more recently low muscle attenuation (MA), as important prognostic indicators of unfavourable outcomes in patients with cancer. Muscle abnormalities can be highly prevalent in patients with cancer (ranging between 10 and 90 %), depending on the cohort under investigation and diagnostic criteria used. Importantly, both low muscle mass and low MA have been associated with poorer tolerance to chemotherapy, increased risk of post-operative infectious and non-infectious complications, increased length of hospital stay and poorer survival in patients with cancer. Studies have shown that systemic antineoplastic treatment can exacerbate losses in muscle mass and MA, with reported loss of skeletal muscle between 3 and 5 % per 100 d, which are increased exponentially with progressive disease and proximity to death. At present, no effective medical intervention to improve muscle mass and MA exists. Most research to date has focused on treating muscle depletion as part of the cachexia syndrome using nutritional, exercise and pharmacological interventions; however, these single-agent therapies have not provided promising results. Rehabilitation care to modify body composition, either increasing muscle mass and/or MA should be conducted, and its respective impact on oncology outcomes explored. Although the optimal timing and treatment strategy for preventing or delaying the development of muscle abnormalities are yet to be determined, multimodal interventions initiated early in the disease trajectory appear to hold the most promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 3×
“Studies (25 – 28) have de fi ned sarcopenia based on cut points developed by Baumgartner et al. (7) in elderly individuals (2-SD below a healthy reference population), by converting the original dual-energy x-ray absorptiometry cut points (<7 · 26 kg/m 2 for men and <5 · 45 kg/m 2 for women) to corresponding CT cut poi…”
BackgroundMethodInfluentialFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 2×
“Hence, several expert groups have proposed the use of both muscle mass and function to define sarcopenia in older adults((23,24,52)).”
BackgroundPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 10×
“Low muscle mass and low MA can occur at any given BMI (kg/m(2))((1,19)), and now with 40–60 % of cancer patients presenting with overweight and obesity((20)), identification of these conditions is becoming increasingly difficult.”
BackgroundMethodInfluentialSelf-citationESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“The rationale for including the measures of both muscle mass and function is that muscle strength does not depend solely on muscle mass, and the relationship between muscle strength and mass is not linear (6) .”
BackgroundMourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 3×
“in elderly individuals (2-SD below a healthy reference population), by converting the original dual-energy x-ray absorptiometry cut points (<7·26 kg/m(2) for men and <5·45 kg/m(2) for women) to corresponding CT cut points using published regression equations((29)).”
BackgroundMethodSelf-citationShen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692 · cited 1×
“Measurements are commonly taken at the third lumber vertebra, as the SMA obtained at this level is a good correlate for whole body muscle in healthy individuals (r 0·92)((22)).”
BackgroundAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
ESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305 · cited 2×
“…optimal protein intake, decreasing in fl ammation and hyper metabolic stress with the aid of anti-in fl ammatory agents (non-steroidal anti-in fl ammatory drugs s and EPA) and increasing physical activity to stabilise/increase muscle mass, strength and physical performance has been recommended (134) .”
BackgroundMeasurement of skeletal muscle radiation attenuation and basis of its biological variation
Aubrey, J., Esfandiari, N., Baracos, V. E., Buteau, F. A., Frenette, J., Putman, C. T., & Mazurak, V. C. (2014) · Acta Physiologica · doi:10.1111/apha.12224 · Cited by 720 · cited 2×
“It represents a ‘ qualitative ’ measure of skeletal muscle, as low radiation attenuation is re fl ective of intra-muscular adipose tissue in fi ltration, and therefore, poor ‘ quality ’ skeletal muscle (11) .”
BackgroundImpact of covert duplicate publication on meta-analysis: a case study
Tramèr, M. R., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (1997) · BMJ · doi:10.1136/bmj.315.7109.635 · Cited by 702 · cited 1×
“The authors included several studies in the review that contained duplicated data, and this is prohibited in a meta-analysis as it may lead to overestimation of an effect (107) .”
BackgroundTemel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention
Prado, C. M. M., & Heymsfield, S. B. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114550189 · Cited by 550
Self-citationImpact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Peng, P., Hyder, O., Firoozmand, A., Kneuertz, P., Schulick, R. D., Huang, D., Makary, M., Hirose, K., Edil, B., Choti, M. A., et al. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1923-5 · Cited by 546
Heymsfield, S. B., Gonzalez, M. C., Lu, J., Jia, G., & Zheng, J. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115000129 · Cited by 483
Skeletal muscle fat infiltration: impact of age, inactivity, and exercise
Marcus, R. L., Addison, O., Kidde, J. P., Dibble, L. E., & Lastayo, P. C. (2010) · The Journal of nutrition, health and aging · doi:10.1007/s12603-010-0081-2 · Cited by 449
Ryan, A. M., Reynolds, J. V., Healy, L., Byrne, M., Moore, J., Brannelly, N., McHugh, A., McCormack, D., & Flood, P. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31819a4789 · Cited by 311
Stene, G. B., Helbostad, J. L., Balstad, T. R., Riphagen, I. I., Kaasa, S., & Oldervoll, L. M. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.001 · Cited by 210
Clinical implications of sarcopenic obesity in cancer
Carneiro, I. P., Mazurak, V. C., & Prado, C. M. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0546-5 · Cited by 162 · cited 1×
“…can be present at any given BMI, and the prevalence of sarcopenic obesity (sarcopenia and obesity (BMI ≥ 30 kg/m 2 )) has been shown to vary between 1 and 29 % in studies including individuals from all BMI categories, and between 15 and 36 % in studies including obese individuals only (59) .”
BackgroundSelf-citationRier, H. N., Jager, A., Sleijfer, S., van Rosmalen, J., Kock, M. C. J. M., & Levin, M.-D. (2017) · The Breast · doi:10.1016/j.breast.2016.10.014 · Cited by 149 · cited 3×
“Recently, low MA has been shown to be prognostic of reduced survival in a variety of different tumours, including lung((18,60)), kidney((64)), breast((14)), gastric((13)), pancreatic((17,65)), periampullary((16)), cholangiocarcinoma((68)), lymphoma((12,15)) and melanoma((109)).”
BackgroundPadilha, C. S., Marinello, P. C., Galvão, D. A., Newton, R. U., Borges, F. H., Frajacomo, F., & Deminice, R. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0592-x · Cited by 149 · cited 2×
“A recent meta-analysis (150) has shown resistance exercise to be effective in increasing muscle strength and mass in cancer patients undergoing neoadjuvant and adjuvant therapy, with mean increases in lower limb strength of 26 · 2 kg ( P = 0 · 00001) and lean mass by 0 · 8 kg ( P 0 · 00001) (150)…”
BackgroundSjøblom, B., Grønberg, B. H., Wentzel-Larsen, T., Baracos, V. E., Hjermstad, M. J., Aass, N., Bremnes, R. M., Fløtten, Ø., Bye, A., & Jordhøy, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.03.010 · Cited by 143 · cited 7×
“Low MA, often referred to as myosteatosis, is emerging as an important prognostic indicator in patients with cancer and in some cases more superior to predicting survival compared with muscle mass alone (12 – 18) .”
BackgroundInfluentialHeywood, R., McCarthy, A. L., & Skinner, T. L. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3827-0 · Cited by 123
Cited by
Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review
Amini, B., Boyle, S. P., Boutin, R. D., & Lenchik, L. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz034 · Cited by 391
“5 cm2/ m2 for women were the most common (33% of studies) (30).”
BackgroundResultInfluentialImplications of low muscle mass across the continuum of care: a narrative review
Prado, C. M., Purcell, S. A., Alish, C., Pereira, S. L., Deutz, N. E., Heyland, D. K., Goodpaster, B. H., Tappenden, K. A., & Heymsfield, S. B. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1511918 · Cited by 286
“Additionally, the assessment of muscle attenuation is also possible; CT-assessed low muscle attenuation is of emerging importance as it may relate to even higher indication of poor patient prognosis, as discussed elsewhere [110,112,113].”
BackgroundSelf-citationDolan, R. D., Almasaudi, A. S., Dieu, L. B., Horgan, P. G., McSorley, S. T., & McMillan, D. C. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12357 · Cited by 181
“Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the o…”
BackgroundInfluentialResearch progress on sarcopenia in the musculoskeletal system
Mao, X., Lv, K., Qi, W., Cheng, W., Li, T., Sun, Y., Jin, H., Pan, H., & Wang, D. (2025) · Bone Research · doi:10.1038/s41413-025-00455-8 · Cited by 37
“35 The study reported that the critical range for SMI at the L3 level, based on abdominal CT scans, aligns closely with the fi ndings of Daly et al. 36 Combining the results, the typical SMI thresholds for sarcopenia were 52 – 55 cm 2 /m 2 in men and 39 – 41 cm 2 /m 2 in women.”
Dolan, R. D., Maclay, J. D., Abbass, T., Colville, D., Buali, F., MacLeod, N., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-77269-7 · Cited by 22
Metadata
- Authors
- Daly, L. E., Prado, C. M., & Ryan, A. M.
- Venue
- Proceedings of the Nutrition Society
- Publisher
- Cambridge University Press (CUP)
- Published
- 2018-05
- Volume
- 77
- Issue
- 2
- Pages
- 135-151
- ISSN
- 0029-6651 (ISSN-L)
- 1475-2719
- OpenAlex
- W2801796280
- Cited by
- 95
- References
- 24
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.